picture of disease burden is available both to the clinician and the patient incorporating a broad range no single system/gold standard being used for remote monitoring 5, 6 . 
144
This has evolved to assessment of multiple motor symptoms using either a single [18] [19] [20] showed greater sensitivity to dysfunction than clinical rating scales 64, 65 . Of interest, free-living 227 assessment appears to discriminate pathology better than testing in the laboratory 54 ( Figure 1 , G).
228
Measurement of functional mobility tasks can therefore be undertaken with a degree of confidence 229 during a standardised test at home, although further work is required to replicate these findings. . All of these 335 potential sources of error should be considered and some suggestions are provided in Table 2 .
337
Determining optimal outcome measures. Tables   Table 1: Studies examining free-living monitoring of Parkinson's disease (PD) using wearable technology and connected devices (WTCD). Number and position of WTDC used in each study is detailed in column two using a colour code (blue = chest, violet = wrist, black = pocket, green = thigh, yellow = shank, orange = ankle, grey = foot, red = lower back). † Clinical feature/ activity detected or measures has been classified using three types of validity: 1) accurate detection of clinical feature/ method of appraisal: the ability of WCTD algorithms to accurately detect a clinical feature/activity which is comparable to detection by another means -in the study cited or previous studies (e.g. self-report, EMG); 2) criterion validity: the association between WTCD-derived outcomes and measures such as clinical scales; and 3) discriminative validity: the ability of WTCD-derived outcomes to discriminative between groups. Formal testing of utility (feasibility/compliance intentionally tested and reported) of WTCD is also reported. 
ALA-6g (PERFORM) --█--█ █ █ █ Walking
Yes, only for step frequency, previous work (see Cancela 2011) Step frequency, step velocity, stride length, entropy No
Yes, only for entropy in previous work 100 Yes, formal testing and also assessed in separate study 76 Herman  Account for influence of context and disease severity on algorithm performance.
 If proprietary software is used ensure transparency of manufacturer algorithms or report published validated algorithm.
Achieve consensus for summary outcomes for comparability across studies.
 Use WTCD-based outcomes validated in free-living; or provide validation results in the current study using semistructured activities.
 Describe (if any) dependence of chosen summary outcomes & on chosen data processing/algorithm.
Figures

Figure 1:
Use of wearable technology and connected devices (WTCD) (adapted with permission from previous work) 47 A) macro level quantification of activities over an extended period of time (volume, patterns and variability); (B) bouts of activities (e.g. lying (sleeping), walking, sitting); (C-H) micro level quantification from specific events: C) and D) postural transitions, E) shuffling, F) gait, G) turning, H) freezing of gait (FOG) and fall. Examples of linear and non-linear approaches to activity data analysis: volume and pattern metrics for two subjects (Subject 1 and 2) (published with permission) 68 . A1 and A2 -Patterns of activity indicating bouts of sedentary, standing and walking at different stepping rates (cadences). B1 and B2 -Volume Metrics: total walking time for the two subjects is equal but made up of walking bouts at different cadences. C -Pattern Metrics: (i) and (ii) distribution of walking bouts for these two subjects with equal mean (M) and different dispersion (S2). C (iii) Accumulation pattern of walking time for subject 1 and 2; subject 2 tends to accumulate walking time with predominantly longer periods. . For example using definition (i) only a small percentage of all the walking bouts will be considered (bouts > 60s only) and therefore fewer steps will be reported if compared to results of using definition (ii). C) Impact of choice in A) on micro gait characteristics (e.g. reported step velocity may vary across studies due to choice of definition ((i), (ii) or (iii)).
Panel (2) -Influence of free-living protocol on data: Walking speed changes with respect to the environment, task, and disease severity which influences the accelerometer raw signal (D) impacting on algorithm performance and evaluation of outcomes (E).
